A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus

Condition:   Cholestasis, IntrahepaticInterventions:   Drug: GSK2330672;   Drug: Placebo;   Drug: Ursodeoxycholic acidSponsor:   GlaxoSmithKlineRecruiting - verified March 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials